Citas bibligráficas
Cabrera, R., (2018). Factores pronósticos de supervivencia de cáncer de mama en el Hospital Nacional Adolfo Guevara Velasco de Essalud Cusco, periodo 2008 – 2017. [Tesis, Universidad Andina del Cusco]. https://hdl.handle.net/20.500.12557/1799
Cabrera, R., Factores pronósticos de supervivencia de cáncer de mama en el Hospital Nacional Adolfo Guevara Velasco de Essalud Cusco, periodo 2008 – 2017. [Tesis]. : Universidad Andina del Cusco; 2018. https://hdl.handle.net/20.500.12557/1799
@misc{renati/1128179,
title = "Factores pronósticos de supervivencia de cáncer de mama en el Hospital Nacional Adolfo Guevara Velasco de Essalud Cusco, periodo 2008 – 2017.",
author = "Cabrera Berrocal, Rómulo Abraham",
publisher = "Universidad Andina del Cusco",
year = "2018"
}
“Prognostic factors of survival of breast cancer in the Adolfo Guevara Velasco National Hospital (HNAGV) EsSalud Cusco, period 2008 - 2017“. Introduction: Survival in breast cancer patients varies according to the time of diagnosis, age, clinical stage, histological pattern, size and location of the tumor. Objective: To identify the prognostic factors of breast cancer survival in HNAGV patients of EsSalud Cusco. Methodology: A retrospective survival study was conducted. The cases were obtained from the cancer unit registry of the HNAGV. Analysis was done by age groups and 5-year survival was calculated. We used the actuarial method and Kaplan-Meier according to variables, with 95% CI and p <0.05 in the SPSSv22.0 program. Results: We analyzed the results of 354 patients, the average age was 53.3 years, the overall survival at 5 years was 79%, the age group from 40 to 49 years have a survival of 88.5%; those who are less than 40 years old 77, 8%. Survival according to clinical stage was 93.3% for stage (0 and I), 88.8% for stage II, 77.4% for stage III and for stage IV 29% (p <0 , 0001). The survival in relation to the histological pattern of the ductal has a survival of 80% and the mixed 94.1%. Conclusions: The 5-year overall survival of patients with breast cancer in HNAGV was 79%. The 5-year survival in early stages (stages 0 and I) was 93.3% and 29% for stage IV. The clinical stage 0 and I, the age group of 40 to 49 years and the location of the tumor in the internal lower quadrant, are prognostic factors of greater survival.
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons